您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
LILRB3/CD85a/LIT5 Fc Chimera Protein, Human

LILRB3/CD85a/LIT5 Fc Chimera Protein, Human

货号: UA010021
价格: 3000
规格: 100μg
介绍: -
其他: -
产品规格
  • 物种

    Human
  • Accession

    O75022
  • 表达序列

    Gly24-Glu443, with C-terminal Human IgG Fc
  • 表达宿主

    HEK293
  • 分子量

    85-95kDa(Reducing)
  • 纯度

    >95%, by SDS-PAGE under reducing conditions
  • 内毒素含量

    <0.1EU/μg
  • 标记

    Unconjugated
  • 标签

    Human Fc Tag
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, pH7.4
  • 溶解方法

    Reconstitute at less than 1 mg/mL according to the size in ultrapure water after rapid centrifugation .
  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.
  • 稀释度

背景介绍
  • LILRB3 is a member of LILRB family that is restrictively expressed on myeloid cells, including monocytes, neutrophils, eosinophils, and basophils (as well as on in vitro differentiated mast cells and osteoclasts). LILRB3 contains four cytoplasmic ITIM motifs hat may contribute to negative regulation of immune response. Ligation of LILRB3 in human myeloid cells led to inhibition of immune activation. LILRB3 may be an inhibitor of allergic inflammation and autoimmunity. However, the ligand for LILRB3 has not been identified, and the downstream signaling of LILRB3 is unclear. It is noteworthy that LILRBs, including LILRB3, are primate specific.

    LILRB3 is also expressed on some myeloid leukemia, B lymphoid leukemia, and myeloma cells. It is reportedly co-expressed with stem cell marker CD34 and with myeloma marker CD138.

  • 电泳JSON

    • LILRB3/CD85a/LIT5 Fc Chimera, Human,1μg on SDS-PAGE under Non-reducing and reducing condition. The purity is greater than 95%.